SEC Form D · filed March 19, 2019
Faraday Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Thomas King · Seattle, WADirectorBrian Blackman · Seattle, WAExecStephen Hill · Seattle, WAExec · DirectorMark Roth · Seattle, WADirector · PromoterSteven Gillis · Seattle, WADirectorSimon Tulloch · Seattle, WAExecParker Spann · St. Louis, MOExecAdam G. Yader · Monterey, CAExecJason G. Klarreich · New York, NYDirectorDavid Richardson · George Town, Cayman IslandsExec · DirectorCandace J. Woods · Newark, NJDirectorAndrew Hersant · George Town, Cayman IslandsDirector · PromoterJanet Kraus · WALTHAM, MADirectorDerek Ohly · WALTHAM, MAExecAndreas Guldin · WALTHAM, MAExecElizabeth Campbell · Long Island City, NYDirectorJoseph Luceri · Long Island City, NYDirector · PromoterScott Perricelli · Long Island City, NYExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗